Chemed Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2024: 25.49%

Chemed Corporation Return on Equity (ROE) is 25.49% for the Trailing 12 Months (TTM) ending September 30, 2024, a -4.89% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Chemed Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2023 was 26.80%, a -31.07% change year over year.
  • Chemed Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2022 was 38.89%, a 9.97% change year over year.
  • Chemed Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2021 was 35.36%, a -3.48% change year over year.
  • Chemed Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2020 was 36.63%.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share